|
|
Re: Analysis of the analytical sample in duplicate
|
Dar Malcolm Ross, Thanks for valuable guidance. This is again a question for me when a HPLC method is validated (for which accuracy and precision is obviously high than other analysis), analyst is validated. Additionally the analytical method is official in the pharmacopoeia then how to decide either to prepare the samples in, 1. Duplicate standard and test preparations and multiple injections 2. or single standard and test preparation and multiple injections What could be the probability for the above cases? or any guideline to decide for the above criteria. Regards, Rupesh Sakhare From: Malcolm Ross (by way of John Dolman <moderator@the-dolman-consultancy.com>) Sent: Friday, February 22, 2008 10:18 AM To: GMP Forum Subject: Re: Analysis of the analytical sample in duplicate The answer has nothing to do with the BP-the answer is in the accuracy and precision of your method as related to your equipment. For example the more sensitive the analytical balance the less material needs to be weighed. On the other hand the number of dilutions and the volume of pipettes. flasks etc. all have a critical effect on accuracy. So their is no simple plug in answer-you must understand the analytical constraints of your method. Malcolm Ross Generapharm-training and consultancy Basel-CH On Fri, Feb 22, 2008 at 11:13 AM, msn mail <rps_pan@hotmail.com> wrote:
Malcolm Ross Generapharm-Training and Consultancy Rümelinbachweg 16 Basel 4054 Switzerland +41 615 34 64 18 |
|
|